February 3, 2025 - 12:44
Genelux has announced the appointment of Matthew Pulisic as its new Chief Financial Officer, a strategic move aimed at bolstering the company’s financial leadership. Pulisic brings with him 19 years of extensive experience in global biopharmaceutical finance, having held significant roles at industry leaders such as Arrowhead and Amgen.
In his new position, Pulisic will be instrumental in driving the company’s commercial growth and financial strategy. His background in managing complex financial operations and fostering investor relations will be vital as Genelux seeks to expand its market presence. The leadership team believes that Pulisic’s proven track record in the biopharma sector will provide valuable insights and guidance during this crucial phase of growth.
This appointment comes at a pivotal time for Genelux as it aims to enhance its operational capabilities and capitalize on emerging opportunities in the biotechnology landscape. With Pulisic at the helm of financial strategies, the company is poised for a promising future.
